ORCHARD THERAPEUTICS PLC-ADR (ORTX)
US68570P2002 - ADR
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -72.92M | -150.66M | -144.58M | -151.98M | -163.42M | |||
| Depreciation Amortization | 2.67M | 2.74M | 2.33M | 2.00M | 1.68M | |||
| Income Taxes - Deferred | -4.47M | -3.28M | 1.13M | -2.26M | N/A | |||
| Change In Working Capital | 3.93M | 36.20M | -17.06M | -3.63M | -17.73M | |||
| Interest Paid | 3.15M | 2.65M | 2.10M | 1.83M | 1.23M | |||
| Taxes Paid | N/A | 160.00K | 1.65M | 1.01M | 1.47M | |||
| Other non cash items | -22.53M | 39.01M | 33.09M | 29.59M | 13.35M | |||
| OPERATING CASH FLOW | -93.32M | -75.99M | -125.10M | -126.27M | -166.13M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.09M | -6.51M | -2.35M | -2.67M | -4.37M | |||
| Other Investing Activity | -24.93M | 97.07M | -29.82M | 160.05M | -304.99M | |||
| INVESTING CASH FLOW | -26.02M | 90.56M | -32.17M | 157.38M | -309.36M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -7.86M | -790.00K | 7.38M | 0.00 | 24.47M | |||
| Stock Issued/Repurchased | 68.32M | 210.00K | 157.44M | 3.94M | 133.59M | |||
| Other Financing Activity | -1.19M | -120.00K | -6.75M | N/A | -610.00K | |||
| FINANCING CASH FLOW | 59.28M | -690.00K | 158.07M | 3.94M | 157.45M | |||
| Exchange Rate Effect | 2.73M | -1.42M | -30.00K | 1.04M | 1.67M | |||
| CHANGE IN CASH | -57.33M | 12.46M | 770.00K | 36.09M | -316.37M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -93.32M | -75.99M | -125.10M | -126.27M | -166.13M | |||
| Capital Expenditure | -1.09M | -6.51M | -2.35M | -2.67M | -4.37M | |||
| FREE CASH FLOW | -94.41M | -82.50M | -127.45M | -128.94M | -170.50M | |||
All data in USD